|
Volumn 15, Issue 10, 2013, Pages 748-751
|
The new hypertension guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CALCIUM;
CALCIUM CHANNEL BLOCKING AGENT;
DIHYDROPYRIDINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
MINERALOCORTICOID ANTAGONIST;
POTASSIUM;
THIAZIDE DIURETIC AGENT;
ALCOHOL CONSUMPTION;
BLOOD PRESSURE MONITORING;
CALCIUM INTAKE;
CANCER SCREENING;
CARDIOVASCULAR RISK;
COMPUTER ASSISTED TOMOGRAPHY;
ECHOCARDIOGRAPHY;
EXERCISE;
HEART FAILURE;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART VENTRICLE HYPERTROPHY;
HOME MONITORING;
HUMAN;
HYPERALDOSTERONISM;
HYPERTENSION;
LIFESTYLE MODIFICATION;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHEOCHROMOCYTOMA;
POTASSIUM INTAKE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RENOVASCULAR HYPERTENSION;
REVIEW;
SCREENING;
SODIUM INTAKE;
STRESS MANAGEMENT;
SYSTOLIC HYPERTENSION;
WEIGHT REDUCTION;
WHITE COAT HYPERTENSION;
BLOOD PRESSURE;
CANADA;
DISEASE MANAGEMENT;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 84884983257
PISSN: 15246175
EISSN: 17517176
Source Type: Journal
DOI: 10.1111/jch.12171 Document Type: Review |
Times cited : (10)
|
References (7)
|